bibliographicCitation |
Xu Q, Xu H, Xue L, Wang M, Pan G, Zhang X, Song K, Yao W, Wan X, Tong J, Liu H, Xu H, Liu X, Zhu X, Sun Z, Yang L, Wang X. CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation. Chin Med J (Engl). 2022 Jan 05;135(1):98–100. PMID: 33967196; PMCID: PMC8850813. |